Neumorphism white abstract eye _edited.jpg

Newsroom

Discover PulseMedica in the news! Read company announcements, development progress, and more.

Featured in

Recent News Story

November 13, 2025

Retina Leader Dr. John Pollack Joins PulseMedica’s Board

Dr. John Pollack, MD, FASRS, retina specialist and industry leader, has joined PulseMedica’s Board of Directors to strengthen clinical oversight and strategic alignment as we advance toward clinical validation and beyond.

Learn More

PulseMedica in the News

Published by:

INOVAIT

May 5, 2025

Developing Revolutionary Technology to Diagnose and Treat vitreoretinal Disease

Introducing the world’s first non-invasive, image-guided laser platform for eye floaters and posterior eye conditions.

Read Article

Published by:

University of Alberta

Oct 17, 2024

Investing in the Next Generation of Entrepreneurs and Innovators

Donor-supported U of A Innovation Fund continues propelling promising startup ventures — including a company putting Alberta at the global forefront of satellite technology.

Read Article

Published by:

AMII

Dec 9, 2024

AI Seminar: Applying ML Technologies to Screen and Treat Eye Floaters

Learn how PulseMedica is applying machine learning to detect, track and treat eye floaters. Presented by Dr. Chris Ceroici.

Watch Video

Published by:

Google for Startups

Sep 17, 2024

Meet the 2024 Google for Startups Accelerator: Canada Cohort

PulseMedica has been selected to participate in the Google for Startups Accelerator: Canada Cohort

Read Article

Published by:

Ophthalmology Innovation Source

Dec 6, 2024

Company Quick Takes

Carey Powers caught up with five innovative companies at this years OIS XIV in San Diego, to discuss the latest advancements in ophthalmology on the OIS podcast.

Listen Now

Published by:

RBCx

Aug 8, 2024

Founder Insights: How Life Sciences Startups Can Acquire Funding

PulseMedica’s two co-founders recently sat down with us to share how they navigated fundraising as a life sciences startup in an uncertain economic climate and advice they’d give to other early-stage founders.

Read Article

5
Page 2